Geneva, April 28 -- International Clinical Trials Registry received information related to the study (NCT07537816) titled 'Effects of Vadadustat on Anemia, Quality of Life, and Inflammation in Dialysis Patients' on April 12.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Mackay Memorial Hospital
Condition:
Renal Anemia
Intervention:
Drug: Vadadustat
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: April 15, 2026
Target Sample Size: 40
To know more, visit https://clinicaltrials.gov/study/NCT07537816
Published by HT Digital Content Services with permission from Heal...